23andMe Democratizes Personal Genetics
23andMe, Inc., the industry leader in personal genetics, today announced a substantial reduction in price for its Personal Genome Service(TM), democratizing personal genetics and expanding the opportunity for more people to benefit from the genetic revolution.
Effective immediately, 23andMe is offering its service for US$399. 23andMe is able to offer the reduced price thanks to technological advancements made by the company that provides its DNA scanning technology, Illumina, Inc. In addition, 23andMe also unveiled today the expansion of its custom genotyping content along with new social…